Ad-hoc | 21 March 2005 15:33

STRATEC: Dividend increased by bonus

Ad hoc announcement §15 WpHG Dividend proposal STRATEC: Dividend increased by bonus Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Dividend increased by bonus – Proposed dividend of Euro 0.15 increased by bonus of Euro 0.05 Birkenfeld, March 21, 2005 Following the conclusion of a highly successful financial year 2004 and in view of the positive assessment of the further development of the company, the Supervisory Board and Board of Management decided at the Supervisory Board meeting held today, which approved the annual financial statements of the company, to propose to the Annual General Meeting the distribution of a bonus of Euro 0.05 per individual bearer share in addition to the planned dividend of Euro 0.15 per individual bearer share (previous year: Euro 0.08). STRATEC Biomedical Systems AG Gewerbestraße 37 75217 Birkenfeld Deutschland ISIN: DE0007289001 WKN: 728900 Listed: Geregelter Markt in Frankfurt (Prime Standard) und Stuttgart; Freiverkehr in Berlin-Bremen, Düsseldorf und München End of ad hoc announcement (c)DGAP 21.03.2005 Issuer’s information/explanatory remarks concerning this ad hoc announcement: In view of its growth-driven corporate strategy, STRATEC will in future continue to make its dividend proposal dependent on the earnings generated in the respective year, the company’s liquidity situation and the liquidity requirements resulting from the prevailing opportunities for growth. The payment of the dividend and the bonus is scheduled for the first banking day following the Annual General Meeting. Our Annual General Meeting for the 2004 financial year will take place at CongressCentrum Pforzheim, Mittlerer Saal, Am Waisenhausplatz 1-3, 75172 Pforzheim, on Wednesday, May 4, 2005. This year’s Annual Results Press Conference will be held in the form of a telephone conference (conference language: German). It will take place on March 31, 2005 at 10.00 a.m.. Press representatives, investors and analysts wishing to take part in this telephone conference are kindly requested to register with our Investor Relations Team (Tel: +49 (0)7082 7916-190). About STRATEC Biomedical Systems AG STRATEC (http://www.stratec-biomedical.de) designs and manufactures fully automated systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems together with their own reagents to laboratories and research institutes around the world. The company develops its products on the basis of its own patented technologies. Shares in the company (WKN: 728900 / ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange, in the Gate-M trading segment of the Stuttgart Stock Exchange and on other exchanges. Further information can be obtained from: STRATEC Biomedical Systems AG Investor Relations André Loy Gewerbestrasse 37 75217 Birkenfeld Germany Tel: +49 (0)7082 7916-190 Fax: +49 (0)7082 7916-999 E-Mail: ir@stratec-biomedical.de End of message (c)DGAP 211533 Mär 05